ArticleFrontiers in immunology2026
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: To address this, we evaluated the impact of PgOMV on human peripheral neutrophil activation, NET formation, metabolic parameters, and intracellular bacterial internalization and persistence, as well as their indirect effects on trophoblast migration. We further compared responses to OMV derived from bacteria grown under basal versus oxidative stress conditions (H Results: PgOMV induced neutrophil activation, as evidenced by increased ROS production and CD11b surface expression. Despite this activation, PgOMV did not trigger NET formation and significantly reduced extracellular DNA through DNase activity, as confirmed using PMA-induced NET preparations. PgOMV stimulation increased glucose uptake and lipid droplet accumulation, reduced lactate release, and decreased both mitochondrial mass and membrane potential. Neutrophils preconditioned with PgOMV displayed significantly greater Pg intracellular internalization and persistence relative to untreated controls, and conditioned media from PgOMV-stimulated neutrophils impaired HTR-8/SVneo trophoblast migration. Comparison of basal and H Conclusions: Together, these findings indicate that PgOMV induce an activated but permissive neutrophil phenotype characterized by activation, impaired extracellular antimicrobial responses, altered metabolic-associated parameters, and increased susceptibility to intracellular bacterial survival and that oxidative stress further enhances bacterial persistence. The impairment of trophoblast migration by PgOMV-conditioned neutrophil media supports an indirect, neutrophil-mediated mechanism through which periodontal-derived vesicles may contribute to placental dysfunction, with implications for the link between periodontitis and adverse pregnancy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.